Effect of tepoxalin on renal function in healthy dogs receiving an angiotensin-converting enzyme inhibitor

Journal of Veterinary Pharmacology and Therapeutics

Volumn 28, Issue 6, 2005, Pages 581-586

  Fusellier, M ^a   Desfontis, J C ^a,b   Madec, S ^a   Gautier, F ^a   Marescaux, L ^a   Debailleul, M ^a   Gogny, M ^a  

^a LUNAM UNIVERSITÉ   (France)

^b UPSP 5304 Laboratoire de Physiopathologie animale et de Pharmacologie fonctionnelle   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; CHLORIDE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; NONSTEROID ANTIINFLAMMATORY AGENT; PENTETATE TECHNETIUM TC 99M; PLACEBO; POTASSIUM; PROPOFOL; RINGER LACTATE SOLUTION; SODIUM; TEPOXALIN; UREA;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR BLOCK; BLOOD CHEMISTRY; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG UPTAKE; ELECTROCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; KIDNEY FUNCTION; KIDNEY SCINTISCANNING; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZAZEPINES; DOGS; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; GLOMERULAR FILTRATION RATE; KIDNEY; KIDNEY FUNCTION TESTS; PYRAZOLES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M PENTETATE;

ANIMALIA; CANIS FAMILIARIS;

EID: 28444473905     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2005.00685.x     Document Type: Article

References (20)

1. Argentieri, D.C., Ritchie, D.M., Ferro, M.P., Kirchner, T., Wachter, M.P., Anderson, D.W., Rosenthale, M.E. & Capetola, J. (1994) Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile. Journal of Pharmacology and Experimental Therapeutics, 271, 1399-1408.
2. Atkins, C.E., Brown, W.A., Coats, J.R. et al. (2002) Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation. Journal of the American Veterinary Medical Association, 221, 654-658.
3. 99mTc-diethylenetriaminepentacetic acid (DTPA) for the evaluation of the glomerular filtration rate in dogs. Veterinary Radiology & Ultrasound, 39, 470-474.
4. Boström, I., Nyman, G., Kampa, N., Häggström, J. & Lord, P. (2003) Effects of acepromazine on renal function in anesthetized dogs. American Journal of Veterinary Research, 64, 590-598.
5. Clària, J. & Arroyo, V. (2003) Prostaglandins and other cyclooxygenase-dependent arachidonic acid metabolites and the kidney in liver disease. Prostaglandins and other Lipid Mediators, 72, 19-33.
6. Corvera, S., Schwarz, K.R., Graham, R.M. & Garcia-Sainz, J.A. (1986) Phorbol ester inhibit alpha 1-adrenergic effects and decrease the affinity of liver cell alpha 1-adrenergic receptors for (-)-epinephrine. The Journal of Biological Chemistry, 261, 520-526.
7. Forsyth, S.F., Guilford, W.G. & Pfeiffer, D.U. (2000) Effect of NSAID administration on creatinine clearance in healthy dogs undergoing anesthesia and surgery. Journal of Small Animal Practice, 41, 547-550.
8. Fusellier, M., Madec, S., Gautier, F., Debailleul, M., Marescaux, L., Gogny, M. & Desfontis, J.-C. (2004) Influence of three anaesthetic protocols on glomerular filtration rate measured by scintigraphy in healthy dogs. Proceedings of the 5th annual scientific Meeting of the European Society of Laboratory Animal Veterinarians, 12-13 June, Nantes, France.
9. Gambaro, G. & Perazella, M.A. (2003) Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. Journal of Internal Medicine, 253, 643-652.
10. Imig, J.D. & Deichmann, P.C. (1997) Afferent arteriolar responses to ANG II involve activation of PLA and modulation by lipoxygenase and P-450 pathways. American Journal of Physiology - Renal Physiology, 273, F157-F163.
11. Kirchner, T., Aparicio, B., Argentieri, D.C., Lau, C. Y. & Ritchie, D.M. (1997) Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5- lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation. Prostaglandins, Leukotrienes, Essential Fatty Acids, 56, 417-423.
12. Kitazawa, H., Eguchi, T., Kitoh, K., Ohba, Y., Kondo, M., Nakano, M. & Sasaki, Y. (2000) Plasma concentrations of an angiotensin-converting enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, after repeated administrations of benazepril in dogs with experimental kidney impairment. Journal of Veterinary Medical Science, 62, 179-185.
13. Ko, J.C.H., Miyabiyashi, T., Mandsager, R.E., Heaton-Jones, T.G. & Mauragis, D.F. (2000) Renal effects of carprofen administered to healthy dogs anesthetized with propofol and isoflurane. Journal of the American Veterinary Medical Association, 217, 346-349.
14. Kochevar, D.T. (2001) Principles of acid-base balance: fluid and electrolyte therapy. In Veterinary Pharmacology and Therapeutics, 8th edn. Eds Adams, H.R. pp. 501-533. Iowa State University Press, Ames, IA.
15. Llinas, M.T., Lopez, R., Rodriguez, F., Roig, F. & Salazar, F.J. (2001) Role of COX-2-derived metabolites in regulation of the renal haemodynamic response to norepinephrine. American Journal of Physiology - Renal Physiology, 281, F975-F982.
16. Lobetti, R.G. & Joubert, K.E. (2000) Effect of administration of non-steroidal anti-inflammatory drugs before surgery on renal function in clinically normal dogs. American Journal of Veterinary Research, 61, 1501-1506.
17. Martin, M.W.S. (2003) Treatment of congestive heart failure - a neuroendocrine disorder. Journal of Small Animal Practice, 44, 154-160.
18. Persson, P., Ehmke, H. & Kirchheim, H. (1988) Influence of the reninangiotensin system on the autoregulation of renal blood flow and glomerular filtration rate in conscious dogs. Acta Physiologica Scandinavica, 134, 1-7.
19. Wallace, J.L., McCafferty, D.M., Carter, L., McKnight, W. & Argentieri, D. (1993) Tissue-selective inhibition of prostaglandin synthesis in rat by tepoxalin: anti-inflammatory without gastropathy. Gastroenterology, 105, 1630-1636.
20. Zubrin® (Tepoxalin) European Public Assessment Report. European Agency for Evaluation of Medicinal Products. Available at: http:// www.emea.eu.int/vetdocs/vets/Epar/zubrin/zubrin.htm. accessed on October 2004.